References
- Autelitano D. J., Clements J. A., Nikolaidis I., Canny B. J., Hinder J. W. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels. Endocrinology 1987; 121: 1689–1696
- Bertolini A., Vergoni A. V., Poggioli R., Gessa G. L. Morphine and beta-endorphin antagonize posture and locomotor disorders induced by the injection of ACTH1-24 in the rat locus coeruleus. Life Sciences 1986; 38: 373–377
- Bloom F., Segal D., Ling N., Guillemin R. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science 1983; 194: 630–632
- DeWied D., Jolles J. Neuropeptides derived from pro-opicortin: behavioral, physiological and neurochemical effects. Physiological Reviews 1982; 62: 976–1059
- Dores R. M., Jain M., Akil H. Characterization of the forms of beta-endorphin and alpha-MSH in the caudal medulla of the rat and guinea pig. Brain Research 1986; 377: 251–260
- Farah I. M., Sapun M. D., Mueller G. P. Dopaminergic inhibition of pituitary beta endorphin-like-immunoreactivity secretion in the rat. Endocrinology 1982; 110: 657–659
- Franceschi M., Cecchetto R., Panerai A. F. Plasma beta-endorphin and beta-lipotrophin in patients with Parkinson's disease. Clinical Neuropharmacology 1986; 9: 549–555
- Hosokawa S., KaTO M. Physiology of peptides in basal ganglia. Progress in brain research, P. C. Emson, M. N. Rossor, M. Tohyama. Elsevier, Amsterdam 1986; Vol. 66: 73–89
- Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorders after unilateral microinjection of ACTH1-24 in the rat brainstem. Science 1982; 218: 175–177
- Javoy-Agid F., Ruberg M., Pique L. Biochemistry of the hypothalamus in Parkinson's disease. Neurology 1985; 34: 672–675
- Laihinen A., Irjala K., Rhine U. K. Prolactin response as an index of dopamine receptor function in Parkinson's disease. Proceeding of Integrative Neurolumoral Mechanisms—Physiological and Clinical Aspects. Budapest 1982
- Langston J. W., Forno L. S. The hypothalamus in Parkinson's disease. Annals of Neurology 1978; 3: 129–133
- Millington W. R., O'Donohue T. L., Mueller G. P. Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat. Journal of Pharmacology and Experimental Theraputies 1987; 243: 160–170
- Nappi G., Petraglia F., Martignoni E., Facchinetti F., Bono G., Genazzani A. R. Beta-endorphin CSF decrease in untreated parkinsonian patients. Neurology 1985; 35: 1371–1374
- Rinne L. K., Rinne J. O., Laakso K., Laihinen A., Lonnberg P. Brain receptor changes in relation to the disease process and treatment. Journal of Neural Transmission, suppl 1983; 18: 279–286
- Rinne U. K., Rinne J. K., Rinne J. O., Laakso K., Tenovuo O., Lonnberg P., Koskinen V. Brain enkephalin receptors in Parkinson's disease. Journal of Neural Transmission, suppl 1983; 19: 163–171
- Sandyk R., Lacono R. P. The hypothalamus in Parkinson's disease. International Journal of Neuroscience 1987; 33: 257–259
- Sandyk R. Hypothalamic-locus coeruleus interaction in the pathophysiology of the “on-off” phenomenon in L-dopa treated parkinsonian patients. International Journal of Neuroscience, (in press)
- Schachter M., Bedard P., DeBono A. G., Jenner P., Marsden C. D., Price P., Parkes J. D., Keenan J., Smith B., Rosenthaler J., Horowski R., Dorrow R. The role of D-1 and D-2 receptors. Nature 1981; 286: 157–159
- Tilders F. J. H., Berkenbosch F., Smelik P. G. Control of secretion of peptides related to adrenocorticotropin. melanocyte stimulating hormone and endorphin. Frontiers in hormones research, T. B. W. Gredanus, S. W. J. Lamberts. Karger, Basel 1985; Vol. 14: 161–196
- Uhl G. R., Hackney G. O., Torchia M., Stranov V. Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal system. Annals of Neurology 1986; 20: 194–203
- Vermes L., Tilders F. J. H., Stoof J. C. Dopamine inhibits the release of immunoreactive beta-endorphin from rat hypothalamus in vitro. Brain Research 1985; 326: 41–46
- Wiesen M., Yahr M. D., Krieger D. T. Plasma beta-lipotrophin levels in Parkinson's disease. Journal of Neural Transmission 1982; 53: 75–82